Synergy CHC Corp is a consumer health care company. It is in the business of marketing and distributing consumer branded products through various distribution channels primarily in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen amongst others. Synergy generates the majority of its revenue from the sale of Flat Tummy Tea, which is exclusively sold online at www.flattummyco.com. Flat Tummy Tea is a uniquely formulated two-step herbal detox tea that works to naturally help speed metabolism, boost energy and reduce bloating.

Synergy CHC Corp.

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

Samuel Levy

Shantanu Gaur

Allurion Technologies Inc.

Biofourmis harnesses the power of technology and data to shape innovations that bring the right care to every person, no matter where they are. The company aims to make care simpler, science smarter, and patients healthier.

Xuejiao Zhao

Kuldeep Rajput

Maulik Majmudar

Biofourmis

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.

Castle Biosciences, Inc.

Synergy CHC is a consumer healthcare and beauty company that offers a portfolio of health and beauty brands.

Synergy CHC

Synergy CHC Corp | 332 followers on LinkedIn. A consumer health care company. | Synergy CHC Corp is a consumer healthcare company that markets and distributes consumer branded products through various distribution channels, primarily in the health and wellness industry.

Stacy Bieber

Vice President of Sales & Marketing at Synergy CHC (Consumer Health Care)

Greg Hollohan

Creative Director / Product Packaging at Synergy CHC Corp

Frederic Paul Carpenter

Chief Financial Officer at Synergy CHC Corp

Brendan Horning

Synergy CHC Corp

Check out the latest Costco Connection USA 🇺🇸 for a look at our new Focus Factor packaging! Focus Factor Original is now on $5 OFF at all Costco Wholesale locations nationwide, for a limited time!

Wow, a remarkable achievement for the Synergy CHC Corp team! Excited to share that we are now listed on the Nasdaq Global Market under the ticker symbol SNYR. This milestone showcases the relentless effort and commitment of every team member. Proud to be part of such a skilled and dedicated group. Being listed on Nasdaq is a significant milestone and a testament to our growth potential. This is just the start of an incredible journey. Congratulations to all at Synergy CHC Corp! Let's keep innovating and pushing boundaries together. The future is bright! #focusfactor #flattummyco #handmd #happyIPOday

Kyle Ross

We are thrilled to announce that our IPO has been officially launched and we will start trading on Nasdaq under the symbol SNYR this morning. A massive congratulations to our amazing team for this incredible achievement!

Focus Factor gets a new look in 2024! The newly updated Focus Factor packaging design ties the FOCUSfactor brain health supplement family together with impactful graphics that highlight the brand as well as its key benefits to promote better consumer shoppability.

Product benefits play a pivotal role in influencing purchasing decisions. The packaging redesign by Flat Tummy Co effectively emphasizes the advantages that consumers can anticipate when integrating these programs into their daily routines.

Our portfolio of innovative consumer healthcare and beauty brands are redefining excellence in their industries. With trusted products in the health and wellness space, we’re working to build a portfolio of best in class brands that make lives brighter & better.

Metric
Company Name	Synergy CHC Corp.	Allurion Technologies Inc.	Biofourmis	Castle Biosciences, Inc.
Symbol	SNYR	ALUR		CSTL
MSH ID	COM:SYNERGYCHC	COM:ALLURION	COM:BIOFOURMIS	COM:CASTLEBIOSCIENCES
Market	STOCKS	STOCKS	PRIVATE	STOCKS
Sector		Healthcare	Healthcare & Health Services	Healthcare
Industry		Medical - Devices	Healthcare Technology	Medical - Diagnostics & Research
Country	US	US	US	US
Stage
Employee Count	36	501	451	638
Website	synergychc.com	allurion.com	biofourmis.com	castlebiosciences.com
LinkedIn	synergy-chc-corp	allurion-technologies	biofourmis
Founders

Metric
Market Cap	48.48M	64.25M	482.57M
Enterprise Value
Monthly Web Traffic	1.76K
Web Traffic Growth	0.83
Valuation
Raised Capital	10M

Metric
Revenue	42.78M	53.47M	219.79M
Revenue (LTM)
Revenue (NTM)
Gross Profit	32.08M	41.50M	164.23M
EBITDA	10.84M	-79.08M	-55.65M
Operating Income	10.81M	-79.08M	-67.98M
Net Income	6.34M	-80.61M	-57.47M
EPS	0.07	-2.27	-2.14
Diluted EPS	0.07	-2.27	-2.14
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.73	0.78	0.80
Operating Profit Margin	0.19	-0.99	-0.05
EBITDA Margin	0.25	-1.48	-0.25
Net Profit Margin	0.06	-0.79	-0.01
Return on Equity		1.00	-0.01
Return on Assets	0.07	-0.61	-0.01
Return on Capital Employed	9.90	12.27	-0.04

SNYR

COM:SYNERGYCHC

Synergy CHC

Last Close

6.24

22/11 21:00

Market Cap

37.43M

Beta: -

Volume Today

37.23K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-0.10	-1.50	-8.33
P/B Ratio	-0.17	-2.10	1.63
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	12.31	2.10	3.28
EV Multiple	59.33	-0.17	10.23K

Metric
Days Sales Outstanding	20.83	156.64	70.34
Days Payables Outstanding	1.05	242.28	60.10
Days Inventory Outstanding	375.05	186.61	60.83
Operating Cycle	469.08	310.82	124.44
Cash Conversion Cycle	469.08	18.37	50.86
Asset Turnover	1.43	1.02	0.59

Metric
Operating Cash Flow	421.73K	-63.98M	-135K
Free Cash Flow	421.73K	-65.59M	-13.76M
Cash Flow to Debt		-0.96	4.12
Operating Cash Flow/Sales		-0.91	0.16
Free Cash Flow Yield	3.28	-0.46	-0.07

Metric
Cash & Equivalents	632.53K	38.04M	98.84M
Accounts Receivable	1.38M	-1.32M	-14.93M
Inventory	3.73M	6.17M	7.94M
Goodwill			10.69M
Debt to Capitalization	5.59	7.35	0.06
Debt to Assets	1.10	0.51	0.03
Current Ratio	0.50	1.30	7.70
Quick Ratio	0.76	1.51	9.02

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01	0.10	0.26
R&D to Revenue		0.42	0.27
SG&A to Revenue	0.19	0.55	0.33